BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 20545619)

  • 1. Progresses in TCM metal-based antitumour agents.
    Chen ZF; Liang H
    Anticancer Agents Med Chem; 2010 Jun; 10(5):412-23. PubMed ID: 20545619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaloid-metal based anticancer agents.
    Chen ZF; Liu YC; Huang KB; Liang H
    Curr Top Med Chem; 2013; 13(17):2104-15. PubMed ID: 23978139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Properties of Traditional Chinese Medicine.
    Yan Z; Lai Z; Lin J
    Comb Chem High Throughput Screen; 2017; 20(5):423-429. PubMed ID: 28093974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) matrine with Ga(III), Au(III), Sn(IV) ions, and DNA binding studies.
    Chen ZF; Mao L; Liu LM; Liu YC; Peng Y; Hong X; Wang HH; Liu HG; Liang H
    J Inorg Biochem; 2011 Feb; 105(2):171-80. PubMed ID: 21194615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fresh platinum complexes with promising antitumor activity.
    Wang X
    Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent researches in metal supramolecular complexes as anticancer agents.
    Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
    Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Good Fashion is Evolution, Not Revolution" - Methods to Enhance Existing Anticancer Medicines, Primarily with the Use of Transition Metal.
    Guzowska M; Kalinowska M; Lewandowski W
    Anticancer Agents Med Chem; 2018; 18(4):476-487. PubMed ID: 29189181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms.
    Lü S; Wang Q; Li G; Sun S; Guo Y; Kuang H
    J Ethnopharmacol; 2015 Dec; 176():177-206. PubMed ID: 26471289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of traditional Chinese herbal medicines in cancer therapy--from TCM theory to mechanistic insights.
    Hsiao WL; Liu L
    Planta Med; 2010 Aug; 76(11):1118-31. PubMed ID: 20635308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review.
    Wei Z; Chen J; Zuo F; Guo J; Sun X; Liu D; Liu C
    J Ethnopharmacol; 2023 Jan; 300():115748. PubMed ID: 36162545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal Complexes in Cancer Treatment: Journey So Far.
    Kumar Singh A; Kumar A; Singh H; Sonawane P; Pathak P; Grishina M; Pal Yadav J; Verma A; Kumar P
    Chem Biodivers; 2023 Apr; 20(4):e202300061. PubMed ID: 36824028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor activities and mechanisms of Traditional Chinese medicines formulas: A review.
    Fan Y; Ma Z; Zhao L; Wang W; Gao M; Jia X; Ouyang H; He J
    Biomed Pharmacother; 2020 Dec; 132():110820. PubMed ID: 33035836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of Fatty Oils from Traditional Chinese Medicine in Cancer Therapy: A Review for Phytochemical, Pharmacological and Clinical Studies.
    Huang Y; Zhu J; Lin X; Hong Y; Feng Y; Shen L
    Am J Chin Med; 2019; 47(4):727-750. PubMed ID: 31094213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development.
    Wang CY; Bai XY; Wang CH
    Am J Chin Med; 2014; 42(3):543-59. PubMed ID: 24871650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCM active ingredient oxoglaucine metal complexes: crystal structure, cytotoxicity, and interaction with DNA.
    Chen ZF; Shi YF; Liu YC; Hong X; Geng B; Peng Y; Liang H
    Inorg Chem; 2012 Feb; 51(4):1998-2009. PubMed ID: 22309171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-Targeted Anticancer Agents.
    Zheng W; Zhao Y; Luo Q; Zhang Y; Wu K; Wang F
    Curr Top Med Chem; 2017 Nov; 17(28):3084-3098. PubMed ID: 28685693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Target Metal-Based Anticancer Agents.
    Chen ZF; Orvig C; Liang H
    Curr Top Med Chem; 2017 Nov; 17(28):3131-3145. PubMed ID: 28982336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.